Colin O'Bryan

Title: Colin O'Bryan: Innovator in Chemical Entities

Introduction

Colin O'Bryan is a notable inventor based in San Diego, CA, who has made significant contributions to the field of chemical entities. With a total of two patents to his name, O'Bryan's work focuses on developing inhibitors for spleen tyrosine kinase (SYK), which have potential applications in treating various disorders, including cancer.

Latest Patents

O'Bryan's latest patents include innovative chemical entities that comprise 6-((1R,2S)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridine-3(2H)-one and certain solid state forms thereof. These patents disclose methods for using these chemical entities to treat disorders such as cancer, showcasing O'Bryan's commitment to advancing medical science.

Career Highlights

Throughout his career, Colin O'Bryan has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Calithera Biosciences, Inc. His experience in these organizations has allowed him to refine his expertise in the development of innovative chemical solutions.

Collaborations

O'Bryan has collaborated with esteemed colleagues such as Rongliang Chen and Tomonori Ichibakase, contributing to the advancement of research in his field. Their combined efforts have furthered the understanding and application of SYK inhibitors.

Conclusion

Colin O'Bryan's contributions to the field of chemical entities and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in treatments for serious health conditions.